Elevated Resting Blood Pressure (
ERBP
) in the prehypertensive range is associated with increased risk of hypertension and cardiovascular disease, the mechanisms of which remain unclear. Prior studies have suggested that
ERBP
may be associated with overactivation and dysregulation of the sympathetic nervous system (
SNS
). We hypothesized that compared to normotensives (≤120/80 mmHg),
ERBP
(120/80–139/89 mmHg) has higher
SNS
activity, impaired arterial baroreflex sensitivity (
BRS
), and increased vascular inflammation. Twenty‐nine participants were studied: 16 otherwise healthy individuals with
ERBP
(blood pressure (
BP
) 130 ± 2/85 ± 2 mmHg) and 13 matched normotensive controls (mean
BP
114 ± 2/73 ± 2 mmHg). We measured muscle sympathetic nerve activity (
MSNA
), beat‐to‐beat
BP
, and continuous electrocardiogram at rest and during arterial
BRS
testing via the
modified Oxford
technique. Blood was analyzed for the following biomarkers of vascular inflammation: lipoprotein‐associated phospholipase A2 (Lp‐
PLA
2), E‐selectin, and intercellular adhesion molecule 1 (
ICAM
‐1). Resting
MSNA
burst frequency (22 ± 2 vs. 16 ± 2 bursts/min,
P
= 0.036) and burst incidence (36 ± 3 vs. 25 ± 3 bursts/100 heart beats,
P
= 0.025) were higher in
ERBP
compared to controls. Cardiovagal
BRS
was blunted in
ERBP
compared to controls (13 ± 2 vs. 20 ± 3 msec/mmHg,
P
= 0.032), while there was no difference in sympathetic
BRS
between groups. Lp‐
PLA
2 (169 ± 8 vs. 142 ± 9 nmol/min/
mL
,
P
= 0.020) and E‐selectin (6.89 ± 0.6 vs. 4.45 ± 0.51 ng/
mL
,
P
= 0.004) were higher in
ERBP
versus controls. E‐selectin (
r
= 0.501,
P
= 0.011) and
ICAM
‐1 (
r
= 0.481,
P
= 0.015) were positively correlated with
MSNA
, while E‐selectin was negatively correlated with cardiovagal
BRS
(
r
= −0.427,
P
= 0.030). These findings demonstrate that individuals with
ERBP
have
SNS
overactivity and impaired arterial
BRS
that are linked to biomarkers of vascular inflammation.